Max India Limited Financial Overview
MAX
Max India
Max India - FY15 Key Highlights
• Board recommends final dividend of Rs. 1 per share
Considerable progress in the journey to bring structural clarity for shareholders:
•
.
-
■ Scheme of Arrangement to split Max India into 3 verticals Max Financial Services (Life
Insurance); Max India (Healthcare, Health Insurance, Senior Living, Corporate Management
Services and others); and Max Ventures and Industries (Specialty Films) has received Stock
Exchanges / SEBI and CCI approvals
■ Scheme has been filed with High Court; shareholder meeting on July 4th. Application for FIPB
approval also filed and IRDA being filed
■ Divestment of clinical research business concluded
EV as at Mar 31, 2015 at Rs 5,232 Cr, after allowing for shareholder dividends of Rs.
240 Cr and share capital buy back of Rs 166 Cr in FY15
Max Life
•
ROEV for FY15 at 28.1% and operating RoEV at 22.3%
• Value of New Business for FY15 at Rs. 460 Cr. and new business margin at 23.4%
•
Max Life wins awards for Quality and Service Excellence at the ASQ World Conference
Max Healthcare
Max Bupa
• To acquire 76% stake in 340-bedded (expandable to 540 beds) NCR based Hospital
(Pushpanjali Crosslay) for Rs 287 Cr. including fresh investment of Rs. 162 Cr.
MHC turns profitable in Q4 with an EBITDA growth of 50% to Rs. 170 Cr.
• Documentation underway for resetting the JV to 51:49. Cash inflow of Rs. 186 Cr.
assuming implementation by June 30, 2015
•
Flagship product, Heartbeat Version 3, wins 'Golden Peacock Innovative
Product/Service Award' for the year 2015
7View entire presentation